The US Anti-Infective Agents Market is witnessing consistent growth due to the increasing incidence of infectious diseases, rising concerns regarding antimicrobial resistance, and continuous advancements in pharmaceutical research. The United States benefits from a highly developed healthcare infrastructure, strong research capabilities, and significant investments in infectious disease...